ResMed (RMD) PT Raised to $267 at KeyBanc Following Last Week's NDR
Tweet Send to a Friend
(Updated - August 31, 2026 8:45 AM EDT)
KeyBanc analyst Brett Fishbin raised the price target on ResMed (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
KeyBanc analyst Brett Fishbin raised the price target on ResMed (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
